Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group

Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group

Standardized treatments for indolent B cell lymphoma primarily consisting of follicular lymphoma (FL) and for mantle cell lymphoma (MCL) have yet to be established. Here the Hokuriku Hematology Oncology Study Group conducted a multicenter prospective study to investigate the efficacy and safety of a...

Full description

Bibliographic Details
Main Authors: Sakai, Tomoyuki, Masaki, Yasufumi, Otsuki, Nozomi, Sakamaki, Ippei, Kishi, Shinji, Miyazono, Takayoshi, Urasaki, Yoshimasa, Murakami, Jun, Satoh, Tomomi, Nakamura, Takuji, Iwao, Haruka, Nakajima, Akio, Kawanami, Takafumi, Miki, Miyuki, Fujita, Yoshimasa, Tanaka, Masao, Fukushima, Toshihiro, Okazaki, Toshiro, Ueda, Takanori
Format: Online
Language:English
Published: Springer US 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537487/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537487/

Similar Items